Partner Success: Nimbus Apollo
Capabilities
Pharmaron is proud to be a part of our partners’ successes, and the Gilead acquisition of Nimbus Apollo, Inc. is certainly no exception.
The Nimbus Apollo program includes the lead compound ‘976, where Pharmaron’s chemistry, biology, DMPK, and process chemistry teams, under the direction of Nimbus scientists, played an instrumental role in discovering this candidate. We continue to be a major partner for Nimbus in their research efforts after the ACC deal with Gilead.
Written with permission by Nimbus.
Learn more about our small molecule services
